[{"Assets_0_Q3_USD":437766000.0,"CommonStockSharesOutstanding_0_Q3_shares":45896393.0,"EarningsPerShareBasic_3_Q3_USD":0.07,"EarningsPerShareBasic_1_Q3_USD":0.0,"EarningsPerShareDiluted_3_Q3_USD":0.06,"EarningsPerShareDiluted_1_Q3_USD":0.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":29444000.0,"NetIncomeLoss_3_Q3_USD":3040000.0,"NetIncomeLoss_1_Q3_USD":175000.0,"StockholdersEquity_0_Q3_USD":330655000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":48046000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":48215000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":46065000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":46101000.0,"Ticker":"AMPH","CIK":"1297184","name":"AMPHASTAR PHARMACEUTICALS, INC.","OfficialName":"Amphastar Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905609900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171109"}]